Profil
Rahul Shrivastav currently works at Indiana University, as Director from 2017 and BioCrossroads, as Board Of Director.
Mr. Shrivastav also formerly worked at the University of Michigan, as Director of Catering from 2014 to 2017.
Mr. Shrivastav received his graduate degree in 2001 from Southern Cross University.
Aktive Positionen von Rahul Shrivastav
| Unternehmen | Position | Beginn |
|---|---|---|
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical, medical device, diagnostics, ag-biotech, health information technology and platforms sectors. It provides financing for seed and early stage capital requirements. | Direktor/Vorstandsmitglied | - |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Private Equity Investor | 01.06.2017 |
Ehemalige bekannte Positionen von Rahul Shrivastav
| Unternehmen | Position | Ende |
|---|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Private Equity Investor | 31.07.2017 |
Ausbildung von Rahul Shrivastav
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Cross University
Southern Cross University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical, medical device, diagnostics, ag-biotech, health information technology and platforms sectors. It provides financing for seed and early stage capital requirements. | Finance |
















